Search Results
1
Study Matches
A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone Administered for a Period of 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS)
The main purpose of this research study is to test whether an experimental drug called edaravone, is effective as treatment against ALS, and if it is safe and well tolerated when given to patients with your illness. The study will compare the efficacy and safety of an oral form of edaravone (a liquid solution that you will swallow) when given in 2 different ways.
Anne Haulman at ahaulman@pennstatehealth.psu.edu or 717-531-0003, ext=289123
All
18 year(s) or older
NCT04569084
Neurology